ALFRED EBERT: Open Payments
NPI 1336231851 · CLINTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,391 in 185 payments from 16 companies in 2025. Trend: 2023 $2,320 · 2024 $3,055 · 2025 $3,391
Food & beverage: $3,391
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $490 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $465 |
| ABBVIE INC. | 30 | $400 |
| Teva Pharmaceuticals USA, Inc. | 26 | $382 |
| Neurocrine BioSciences, Inc. | 16 | $332 |
| Alkermes, Inc. | 15 | $325 |
| E.R. Squibb & Sons, L.L.C. | 17 | $291 |
| Janssen Pharmaceuticals, Inc | 14 | $213 |
| Vanda Pharmaceuticals Inc. | 5 | $90 |
| Tris Pharma Inc | 3 | $73 |
Products named: CAPLYTA, VRAYLAR, INGREZZA, COBENFY, ABILIFY MAINTENA, UZEDY, REXULTI, ARISTADA.
Industry payments across SC — which companies pay providers there.
